Friday, November 07, 2025
1:30 p.m. – 2:30 p.m. ET
Please note this TeleECHO program is 1:30 p.m. Eastern, 12:30 p.m. Central, 11:30 a.m. Mountain and 10:30 a.m. Pacific.
PRESENTING FACULTY
 |
Pushpa Narayanaswami, MD, FAAN Professor of Clinical Neurology Harvard Medical School Vice Chair, Clinical Operations Department of Neurology Beth Israel Deaconess Medical Center Boston, Massachusetts |
PROGRAM OVERVIEW
This educational program series provides a comprehensive review of FcRn antagonists for the management of generalized myasthenia gravis (gMG). The program explores the mechanism of action of this therapeutic class, alongside an analysis of efficacy and safety data derived from the pivotal clinical trials that supported their regulatory approval. Through interactive case-based discussions, participants will gain insights into the practical application of FcRn antagonists in clinical settings, enhancing their ability to integrate these therapies into patient care.
TARGET AUDIENCE
The proposed education is tailored for neurologists, neuromuscular specialists, nurse practitioners, and physician assistants engaged in the management of patients with generalized myasthenia gravis (gMG).
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the MoA and the potential for FcRn antagonists to address remaining therapeutic unmet needs for appropriate patients with gMG
- Utilize clinical efficacy and safety data for FcRn antagonists, along with best practices for dosing and safety profile optimization, for the development of individualized treatment plans for patients with gMG
- Adopt SDM approaches to incorporate patient preferences into gMG treatment plans and facilitate continued open communication
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
